Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Are Respectively Associated with Prognosis of Gastric Cancer with Liver Metatasis Undergoing and without Hepatectomy

Table 1

Characteristics and survival analysis of all patients of GCLM.

Patients	All GCLM			GCLM undergoing hepatectomy			GCLM without hepatectomy
Parameter	(%)			(%)			(%)
		Univariate	Multivariate		Univariate	Multivariate		Univariate	Multivariate
Gender		0.409	0.258		0.078	0.111		0.477	0.254
Male	299 (79.9)			43 (79.6)			256 (80.0)
Female	75 (20.1)			11 (20.4)			64 (20.0)
Age (57 ± 11)		0.038^∗	0.404		0.341	0.722		0.151	0.489
<58	191 (51.1)			29 (53.7)			162 (50.6)
≥58	183 (48.9)			25 (46.3)			158 (49.4)
T stage		0.144	0.796		0.417	0.067		0.724	0.972
T4b	226 (60.4)			25 (46.3)			201 (63.6)
Not T4b	148 (39.6)			29 (53.7)			119 (36.4)
N stage		0.027^∗	0.508		0.234	0.481		0.389	0.770
N0 or N1	122 (32.6)			18 (33.3)			104 (32.5)
N2 or N3	252 (67.4)			36 (66.7)			216 (67.5)
Number of liver metastases		0.048^∗	0.560		0.824	0.444		0.562	0.433
Single	158 (42.2)			38 (70.4)			120 (37.5)
Multiple	215 (57.8)			16 (29.6)			200 (62.5)
Gastrectomy		0.001^∗	0.059		‐‐‐	‐‐‐		0.037^∗	0.096
Yes	159 (42.5)			54 (100.0)			105 (36.0)
No	215 (57.5)			0 (0.0)			215 (64.0)
Hepatectomy		0.001^∗	0.001^∗
Yes	54 (14.4)
No	320 (85.6)
Chemotherapy		0.016^∗	0.015^∗		0.278	0.167		0.011^∗	0.021^∗
Yes	160 (42.8)			24 (44.4)			136 (42.5)
No or Unknown	214 (57.2)			30 (55.6)			184 (57.5)
PNI		0.001^∗	0.113		0.001^∗	0.001^∗		0.307	0.871
<46.8	140 (37.4)			17 (31.5)			123 (38.4)
≥46.8	234 (62.6)			37 (68.5)			197 (61.6)
NLR		0.001^∗	0.099		0.127	0.733		0.001^∗	0.001^∗
<2.86	201 (53.7)			35 (64.8)			166 (49.6)
≥2.86	173 (46.3)			19 (35.2)			154 (50.4)

.